Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study
Authors:
- Djamilla Madelung MogensenDMDjamilla Madelung Mogensen
- Maria Bergkvist PihlMPMaria Bergkvist Pihl
- Niels E. SkakkebækNSNiels E. Skakkebæk
- Helle Raun AndersenHAHelle Raun Andersen
- Anders JuulAJAnders Juul
- Henriette Boye KyhlHKHenriette Boye Kyhl
- Shanna SwanSSShanna Swan
- David Møbjerg KristensenDKDavid Møbjerg Kristensen
- Marianne Skovager AndersenMAMarianne Skovager Andersen
- Dorte Vesterholm LindDLDorte Vesterholm Lind
- Tina Kold JensenTJTina Kold Jensen
Open Access
- 21 June 2017
- journal article
- research article
- Published by Springer Nature in Environmental Health
- Vol. 16 (1) , 1-8
Abstract
Vaginal candidiasis is frequent among pregnant women and it is treated with anti-fungal medication (conazoles). Conazoles have anti-androgenic properties and prenatal exposure in rodents is associated with a shorter (less masculine) anogenital distance (AGD) in male offspring. To our knowledge this has never been studied in humans. In the Odense Child Cohort pregnant women residing in Odense municipality, Denmark, were recruited at gestational age 8–16 weeks between 2010 and 2012. Of the eligible 2421 mother-child pairs, 812 mother-son pairs were included. Questionnaire data on medicine use were collected in first and third trimester and physical examination at age 3 month was performed. Ano-scrotal distance; measured from the centre of anus to the posterior base of scrotum (AGDas). Ano-cephalad distance; measured from the centre of anus to the cephalad insertion of the penis (AGDap) and penile width; measured at the base of the penis. Eighty seven women had used antifungal medicine during pregnancy. Maternal use of oral fluconazole (n = 4) was associated with a 6.4 mm shorter AGDas (95% CI: -11.9;-0.9) in the male offspring. Use of antifungal vaginal tablets (n = 21), was associated with a non-significantly shorter AGDas (−1.9 mm; 95% CI: -4.3; 0.5) whereas exposure to vaginal cream (n = 23) was not associated to AGDas. Use of antifungal medicine in the window of genital development between 8 and 14 weeks of gestation was associated with a larger reduction in AGDas than exposure outside this window. Antifungal medicine intake was not associated with AGDap and penil width. Our preliminary findings prompted us to hypothesize that maternal use of conazole antifungal medication during pregnancy may affect the masculinization of male offspring. If confirmed, pregnant women should be advised to use antifungal medicine with caution.Keywords
Funding Information
- The danish research council (4004-00352B_FSS)
- Ronald McDonald Children Foundation
- K. A. Rohde's and wife's Foundation
- Odense University Hospital and Region of Southern Denmark
- Municipality of Odense
- The Danish Council for Strategic Research, Program Commission on Health, Food andWelfare (2101-08-0058)
- Odense University Hospital Research Foundation and Odense Patient data Exploratory Network (OPEN)
This publication has 35 references indexed in Scilit:
- Use of Oral Fluconazole during Pregnancy and the Risk of Birth DefectsNew England Journal of Medicine, 2013
- Endocrine disrupting chemicals and disease susceptibilityThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Shorter Anogenital Distance Predicts Poorer Semen Quality in Young Men in Rochester, New YorkEnvironmental Health Perspectives, 2011
- Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticalsReproductive Toxicology, 2010
- Androgen action in the masculinization programming window and development of male reproductive organsInternational Journal of Andrology, 2010
- Synergistic Disruption of External Male Sex Organ Development by a Mixture of Four AntiandrogensEnvironmental Health Perspectives, 2009
- Endocrine-Disrupting Chemicals: An Endocrine Society Scientific StatementEndocrine Reviews, 2009
- Meeting Report: Measuring Endocrine-Sensitive Endpoints within the First Years of LifeEnvironmental Health Perspectives, 2008
- Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidismJournal of Clinical Investigation, 2008
- Antifungal drugs and the risk of selected birth defectsAmerican Journal of Obstetrics and Gynecology, 2008